PROTECTIVE EFFECT OF P2Y14 RECEPTOR INHIBITION IN ISCHEMIA-INDUCED ACUTE KIDNEY INJURY: TOWARD THE DEVELOPMENT OF A NOVEL THERAPEUTIC STRATEGY

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
PROTECTIVE EFFECT OF P2Y14 RECEPTOR INHIBITION IN ISCHEMIA-INDUCED ACUTE KIDNEY INJURY: TOWARD THE DEVELOPMENT OF A NOVEL THERAPEUTIC STRATEGY

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Jean-Philippe C
Lavoie
Jean-Philippe C Lavoie jean-philippe-c.lavoie.1@ulaval.ca Université Laval Department of Obstetrics, Gynecology, and Reproduction, Faculty of Medicine Québec Canada *
Christine Légaré christine.legare@crchudequebec.ulaval.ca CHU de Québec - Université Laval Research Center Reproduction, mother and youth health Research Axis Québec Canada -
Sonia Francoeur sonia.francoeur@crchudequebec.ulaval.ca CHU de Québec - Université Laval Research Center Animal Facility Québec Canada -
Emma Cavarocchi emma.cavarocchi.1@ulaval.ca Université Laval Department of Obstetrics, Gynecology, and Reproduction, Faculty of Medicine Québec Canada -
Patrick Caron patrick.caron@crchudequebec.ulaval.ca CHU de Québec - Université Laval Research Center Endocrinology and Nephrology Research Axis Québec Canada -
Mohammad M. Al-bataineh mma57@pitt.edu University of Pittsburgh School of Medicine Renal-Electrolyte Division, Department of Medicine Pittsburgh United States -
David R. Emlet dre12@pitt.edu University of Pittsburgh School of Medicine Department of Cell Biology Pittsburgh United States -
Nicolas Flamand Nicolas.Flamand@criucpq.ulaval.ca Université Laval Department of Medicine, Faculty of Medicine Québec Canada -
Chantal Guillemette Chantal.Guillemette@crchudequebec.ulaval.ca Université Laval Faculty of Pharmacy Québec Canada -
Siamak Mohammadi siamak.mohammadi@fmed.ulaval.ca Université Laval Department of Surgery, Faculty of Medicine Québec Canada -
Sylvie Breton sylvie.breton@crchudequebec.ulaval.ca Université Laval Department of Obstetrics, Gynecology, and Reproduction, Faculty of Medicine Québec Canada -